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Abstract  
Study Objectives: Sleep is a plausible target for public health promotion. We 
examined the association of changes in sleep with subsequent health and wellbeing 
in the general population. 
Methods: We analysed data from the UK Household Longitudinal Survey, involving 
30,594 people (aged >16) who provided data on sleep and health and wellbeing at 
both Wave 1 (2009-2011) and Wave 4 (2012-2014) assessments. Predicting 
variables were changes in sleep quantity, sleep quality, sleep medication use over 
the 4-year period. Outcome variables were the General Health Questionnaire (GHQ-
12) and the 12-Item Short Form Health Survey (SF-12) mental (MCS) and physical 
(PCS) component scores at Wave 4. Linear regression on each outcome was fully 
adjusted for potential confounders and baseline values of the relevant predicting and 
outcome variables.  
Results: Better outcomes were associated with an increase in sleep duration [GHQ:	  
β=	  1.031	  (95%	  CI:	  -­‐1.328,-­‐0.734)	  MCS:	  1.531	  (1.006,2.055);	  PCS:	  -­‐0.071(-­‐0.419,0.56)],	  
sleep quality [GHQ:	  β=	  -­‐2.031	  (95%	  CI:	  -­‐2.218,-­‐1.844);	  MCS:	  3.027	  (2.692,3.361);	  PCS:	  0.924	  (0.604,1.245)],	  and a reduction in sleep medication use [GHQ:	  β=	  -­‐1.929	  (95%	  CI:	  -­‐2.400,-­‐1.459);	  MCS:	  3.106	  (2.279,3.933);	  PCS:	  2.633	  (1.860,3.406)]. Poorer 
outcomes were on the other hand associated with a reduction in sleep duration, a 
decrease in sleep quality, and an increase in sleep medication use. Changes in sleep 
quality yielded the largest effects on the health and wellbeing outcomes. 	  
Conclusions: Changes in sleep were temporally associated with subsequent health 
and wellbeing. Initiatives that aim to protect a critical amount of sleep, promote sleep 
quality, and reduce sleep medication use may have public health values.
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Statement of Significance:  
Sleep is gaining traction as a health and wellbeing topic in recent years, with more 
and more evidence showing that poor sleep is a risk factor of a range of non-
communicable diseases and even increased mortality. Helping people to achieve a 
healthy sleep pattern may be a cost-effective way to promote wellbeing, but there is 
little empirical evidence that sleep improvements (in a non-clinical context) is followed 
by better health and wellbeing outcomes. This paper examined the potential benefits 
of positive sleep changes on health and wellbeing in the general population from an 
epidemiological angle. Using data from the UK Household Longitudinal Study, we 
found that positive changes in sleep duration, sleep quality, and sleep medication use 
over a period of 4 years are temporally associated with better subsequent health and 
wellbeing. Initiatives that aim to protect a critical amount of sleep, promote sleep 
quality, and reduce sleep medication use may have public health values. 
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1. Introduction  
Sleep is increasingly recognised as a vital part of public health 1-5. Sleeplessness has 
now been linked to problems with daytime functioning and vehicle and occupational 
accidents 6-8. The increased awareness is also explained by the emerging 
connections of sleep with health and wellbeing, whereby excessively long or short 
sleep duration, poor sleep quality, and chronic use of sleep medication have been 
identified as predictors of adverse outcomes. The most convincing evidence has 
come from longitudinal studies, showing that people reporting these sleep issues are 
at greater risk for developing depression 9, obesity 10, type II diabetes 11, 
hypertension 12, and cardiovascular disease 13, directly and indirectly contributing to 
higher risks of mortality 14-16.  
 
These findings highlight sleep as a profitable treatment target for a number of long-
term conditions. However, in examining the public health benefits of early sleep 
interventions, we have limited evidence outside of the clinical context that sleep 
parameters are amenable to positive change over time, and that positive changes in 
sleep duration, quality and sleep medication use are associated with better health 
and wellbeing outcomes in the general population.  
 
Only a handful of population-based longitudinal studies have investigated the 
prospective effect of sleep changes on health and wellbeing. Analyses of data from 
the Whitehall II study have indicated that a reduction of sleep duration to <6 hours 
per night, over a period of 5 years, is associated with lower scores on a range of 
memory and cognitive function tests including the Mini Mental State Examination, an 
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instrument commonly used to assess progression of dementia 17. Such reduction in 
nightly sleep duration is also associated with higher levels of C-reactive protein 
(CRP) and interleukin-6 (IL-6) over the 5-year period 18. Both CRP and IL-6 are 
biomarkers of inflammation with implications for the development of cardiovascular 
disease, cancer and depression 19. Whereas, analyses of data from the Quebec 
Family Study have revealed that short sleepers increasing their nightly sleep duration 
from <6 to 7-8 hours were less likely to gain weight and adiposity over a period of 6 
years, compared to those who maintain a short sleep duration 20, 21. Although these 
findings suggest a role for sleep in cognitive functioning and weight control, the 
extent to which changes in sleep impact on our health and wellbeing has not been 
examined. Further, little is understood about the effect of changes in other important 
sleep parameters such as sleep quality and sleep medication use. The only 
population-based study that looked at changes in these parameters found no effect 
for sleep quality change, but a significant increase in mortality risk among those who 
switched status from non- or infrequent- to frequent-users of sleep medication 22.  
 
To address these gaps in knowledge, the current study examined changes in sleep in 
the general population and the effect of both positive and negative changes in sleep 
on health and wellbeing, using data from the UK Household Longitudinal Survey. We 
captured changes in sleep duration, sleep quality and use of sleep medication over a 
period of 4 years, and we used changes in these parameters to predict outcomes 
reported at the end of the 4-year period. It was hypothesised that an increase in 
sleep duration and a reduction in sleep medication use would be associated with 
better outcomes, whereas a reduction in sleep duration and an increase in sleep 
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medication use would be linked to poorer outcomes at 4-year. No prediction was 
made for changes in sleep quality given the absence of prior evidence.  
 
2. Method   
2.1 Study design 
We analysed Wave 1 (2009-2011) and Wave 4 (2012-2014) data drawn from the UK 
Household Longitudinal Study (UKLHS) 23, a major panel study that supersedes and 
incorporates the British Household Panel Survey (BHPS). The University of Essex 
granted ethical approval to the study. Detailed description of the design and conduct 
of the survey can be found elsewhere 24. A total of 18 waves of annual assessment 
are planned. Each wave of data collection spans over 2 years. At the time of writing, 
only the first 5 waves of data have been released, and of particular relevance to our 
analysis plan, Wave 4 repeated for the first time the same sleep questions 
administered in Wave 1. The data were retrieved and analysed under the regular UK 
Data Service’s End User Licence. Figure 1 summarises the participant constitution of 
the UKHLS at Wave 1 and Wave 4, and the response rate by household data 
collection structure. 
 
(Insert Figure 1 about here) 
 
Both Wave 1 and Wave 4 samples consisted of a general population sample (GP) 
and a booster sample of minority ethnic groups (EMB). However, Wave 4 also 
incorporated a sample of BHPS whose involvement in the UKHLS began at Wave 2. 
The GP sample was selected from postal addresses, using a proportionally stratified, 
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clustered and equal probability approach. The EMB sample was recruited through 
over-sampling of areas with a higher population density of 5 targeted ethnic minority 
groups; Indian, Pakistani, Bangladeshi, Black Caribbean, and Black African.  
 
The data collection method followed the structure of a household. Within each 
household, only 1 person completed the household enumeration grid and the 
household interview. Each member of the household aged over 16 had an individual 
interview and a self-completed questionnaire.  
 
At Wave 1 25, 45,431 eligible households were identified for the GP sample, 10,253 
for the EMB sample. Of these, interviews were achieved with 57% (26,057) of the GP 
and 40% (4,060) of the EMB households. Within these interviewed households, 
individual interviews were completed with 82% of adults (aged 16 or over) in the GP 
sample and 73% in the EMB sample. Of these adult respondents, 87% (n=41,046) of 
those in the GP sample and 70% (n=6,683) of those in the EMB sample also 
completed a paper self-completion questionnaire, which contained questions about 
sleep habits, health and wellbeing that were used in the current study. 
 
At Wave 4 26, 31,447 eligible households were identified. Of these, 21,497 were from 
the GP sample, 3,110 the EMB sample, and 6,840 the BHPS sample. The overall 
response rate was 62% at the household level. Within these interviewed households, 
92% of all eligible adults (n=47453) gave individual interviews and >80% of these 
interviewed individuals also returned a self-completion questionnaire (93% in the GP 
sample, 83% EMB sample, and 94% BHPS), which included the same questions 
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about sleep habits, health and wellbeing asked in Wave 1.   
 
2.2 Participants 
For the current study, 30,594 people provided self-completion data at both Waves 1 
and 4, allowing for longitudinal comparison. 
 
2.3 Assessment of predictors, outcomes and potential confounders 
The key sleep parameters of interest were (i) sleep quantity, (ii) sleep quality, and (iii) 
use of sleep medication. In both waves of assessments, sleep quantity was 
calculated from the question that asked, “How many hours of actual sleep did you 
usually get at night during the last month?” (“hh:mm”). Sleep quality was measured 
using the question, “During the past month, how would you rate your sleep quality 
overall?” (“very good”, “fairly good”, “fairly bad”, or “very bad”). Use of sleep 
medication was checked with the question, “During the past month, how often have 
you taken medicine (prescribed or ‘over the counter’) to help you sleep?” (“not during 
the past month”, “less than once a week”, “once or twice a week”, or “three or more 
times a week”). These sleep questions were modified from select items of the well-
validated Pittsburgh Sleep Quality Index (PSQI) 27. The wording, timeframe, and 
response scale of the questions were exactly the same. The PSQI has good internal 
consistency ( and test-retest reliability 28, 
29. 
 
Predicting variables were changes in these sleep parameters between Waves 1 and 
4 assessments. For both sleep quantity and use of sleep medication, the three 
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derived response categories were “increase”, “no change”, and “decrease”; for sleep 
quality, “better”, “no change”, or “worse”. The number of subjects and their response 
categories across assessment points for each of these sleep parameters are shown 
in Supplementary Tables 1-3. 
 
(Insert Supplementary Tables 1-3 about here) 
 
Outcome variables were health and wellbeing, measured with the 12-item General 
Health Questionnaire (GHQ-12; likert scoring) 30, 31 and the 12-item Short-Form 
Health Survey (SF-12) 32 at Wave 4. The GHQ-12 is an established self-report 
measure for assessing psychological comorbidity in non-psychiatric, community 
settings. The SF-12 is a well-validated scale for measuring health-related quality of 
life. It gives two component summary scores, Mental Component Summary (MCS) 
and Physical Component Summary (PCS), which were used as separate outcome 
variables in the current study.  
 
Potential confounders taken into consideration were demographics variables 
assessed at Wave 1, including age, sex, ethnicity, education and employment status, 
and body mass index (BMI). In addition, baseline values of the relevant predicting 
sleep variables, GHQ-12, MCS, and PCS were entered to the model to adjust for 
differences in symptom presentation.  
 
2.4 Analysis 
We first analysed how the Wave 4 measurement of GHQ-12, PCS, and MCS were 
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associated with each of the key sleep-change parameters. Each analysis was 
restricted to only the subjects who provided data for the outcome variables at both 
Waves 1 and 4, because cases with incomplete outcomes but complete predictors do 
not contribute to the regression of interest if the outcome is missing at random, or will 
cause modelling issues if the outcome is not missing at random 33, 34. This led to a 
sample size of 22,396 for GHQ-12 and 25,431 for both PCS and MCS. We further 
restricted the analysis to those who had complete data on both Waves 1 and 4 
measurements on the key sleep-change parameters as well as the confounders of 
interest. We investigated the sensitivity of our results to these further restrictions by 
using multiple imputation by chained equations 35-37 (See Appendix 1).  
 
Our first analysis on each of the outcomes was a linear regression on the outcome 
measurement at Wave 4 on each of the key sleep-change parameters, whilst 
accounting for the baseline outcome measurement, the potential confounders, and 
baseline measurement of the sleep parameters. In the estimation of the parameters, 
longitudinal weights computed by UKHLS were applied to the regression analysis. 
These weights apply to individual data from Waves 1 to 4 representing adult 
populations who continued to live in the UK at both time points; they accounted for 
unequal selection probability, potential sampling biases, and participants non-
response 38. We adjusted for confounders by means of multivariable adjustment. We 
computed the local effect size of each sleep predictor using Cohen’s , which 
quantifies the proportion of variance explained by adding a sleep predictor to the 
model with confounders alone 38.  
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All analyses were carried out in R (http://www.r-project.org).  
 
3. Results  
3.1 Participant Characteristics 
Table 1 presents the baseline demographic characteristics of the participants by 
analysis. The sample characteristics were highly similar across analyses. Based on 
the complete case analysis, over half of the participants were consisted of female 
participants (56.037%), with a mean age of 47.166 years and a mean BMI of 26.268. 
The majority of the samples were white (87.957%), in full-time employment 
(44.483%), and did not have a university first degree (49.358%) 
 
At baseline, most of the participants reported an average sleep duration of 6-8 hours 
per night (77.0%). The remainder of the participants were split evenly into two 
camps, with 11.7% reported sleeping less than 6 hours and 11.3% more than 8 hours 
a night. Whilst the majority considered their sleep quality to be fairly (53.8%) or very 
good (24.3%), a fifth of the participants regarded their sleep quality fairly (18.2%) or 
very bad (3.8%). Nearly 16% of the participants reported sleep medication use in the 
past month, with 8.8% taking sleep medications >3 times a week. Values of mean 
scores on the GHQ-12 (10.9), MCS (51.1), and PCS (50.4) were within the normative 
range 30, 32. 
 
Changes in sleep quantity, sleep quality, and use of sleep medications were 
observed over the 4-year period, although stability in these parameters appeared to 
be the default (Tables 1-3). Twice as many participants reported a decrease (18.9%) 
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than an increase (9.4%) in sleep quantity. Change in sleep quality was split between 
both directions, with 24.5% noting better sleep quality and 21.2% noting worse sleep 
quality over time. The number of participants reporting a reduction in sleep 
medication use (13.4%) was nearly 3 times higher than those reporting an increase 
(5%).  
 
(Insert Table 1 about here) 
 
3.2. Effect of sleep changes on Wave 4 GHQ-12  
Table 2 presents the parameter estimates of all predictors included in the regression 
models. Adjusted for the Wave 1 GHQ-12 score and all potential confounders, both 
an increase and a decrease in sleep quantity were found to be independent 
predictors of Wave 4 GHQ-12 score, and yielded an effect size of . A 
decrease in sleep quantity was associated with a higher subsequent GHQ-12 score 
, suggestive of more psychiatric symptoms, 
whereas an increase in sleep quantity was associated with a lower GHQ-12 score 
( . Changes in sleep quality yielded an effect 
size of  and worse sleep quality was associated with a higher GHQ-12 
score  and better sleep quality was associated with 
a lower GHQ-12 score . The same pattern of 
findings were also observed for changes in sleep medication use, which yielded an 
effect size of ; an increase in sleep medication use was associated with a 
higher Wave 4 GHQ-12 score  and a decrease in 
sleep medication a lower GHQ-12 score at Wave 4 
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. 
 
(Insert Table 2 about here) 
 
3.3 Effect of sleep changes on Wave 4 MCS  
Table 3 summarises the results of the same analyses carried out with Wave 4 MCS 
score as the outcome variable. Adjusted for the Wave 1 MCS score and all potential 
confounders, changes in sleep quantity were found to be independent predictors of 
Wave 4 MCS score, and yielded an effect size of . A decrease in sleep 
quantity was associated with a lower subsequent MCS score 
, suggestive of poorer mental health, whereas 
an increase in sleep quantity was associated with a higher MCS score 
. As for changes in sleep quality, which yielded an 
effect size of , there were associations between worse sleep quality and a 
lower MCS score and between better sleep 
quality and a higher MCS score . Changes in sleep 
medication use yielded an effect size of , and an increase in sleep 
medication use was associated with a lower MCS score 
, and a decrease in sleep medication a higher 
MCS score at Wave 4 .  
 
 (Insert Table 3 about here) 
 
3.4 Effects of sleep changes on Wave 4 PCS  
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Table 4 presents the results of the same analyses with Wave 4 PCS score as the 
outcome variables. Adjusted for Wave 1 PCS score and all potential confounders, 
changes in sleep quantity yielded an effect size of , and a decrease in 
sleep quantity was associated with a lower subsequent PCS score 
, suggestive of poorer physical health, but no 
effect was found for an increase in sleep quantity 
. Changes in sleep quality yielded an effect 
size of and worse sleep quality was associated with a lower PCS score 
 and better sleep quality a higher PCS 
score . Likewise, an increase in sleep medication 
use was associated with a lower , and a 
decrease in sleep medication a higher, PCS score at Wave 4 
, and changes in sleep medication use yielded an 
effect size of .  	  
(Insert Table 4 about here) 
 
3.4. Sensitivity analysis 
We performed our analysis on each of the imputed data sets to investigate the 
sensitivity of our conclusions relative to the complete case analysis. The conclusions 
drawn from our analyses did not differ using the imputed data sets.  
 
4. Discussion  
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Changes in all sleep parameters were associated with subsequent measures of 
health and wellbeing. There was a high level of consistency across the findings from 
different analyses by outcome, indicating that poorer outcomes were predicted by a 
reduction in sleep duration, a decrease in sleep quality, and an increase in sleep 
medication use. Better outcomes on the other hand were predicted by an increase in 
sleep duration, an improvement in quality, and a reduction in sleep medication use. 
Importantly, effects of these sleep parameters were independent of baseline health 
status and a number of known confounders.  
 
Of all predictors, effects on health and wellbeing were largest for changes in sleep 
quality ( ), followed by changes in sleep medication use 
(  and then changes in sleep quantity (  (see 
Figure 2). Whilst negative changes in sleep generally had larger effects on health and 
wellbeing, positive changes in sleep were associated with an up to 2-point reduction 
on the GHQ-12 and a 3-point increase on the MCS and PCS. These levels of change 
on the MCS and PCS translate to “some less” to “a lot less” physical and mental role 
limitations according to the SF-12 scoring and interpretation manual 27. Changes on 
the GHQ are comparable to those seen in mental health professionals completing a 
8-week programme of mindfulness-based cognitive therapy designed to improve 
psychological wellbeing (1.6-point reduction at 20-week follow-up) 25. They are also 
comparable to the average improvement in wellbeing (1.4-point reduction) shown by 
UK BHPS lottery winners 2 years after a medium-sized (£1000 - £120,000 in 1998 
money) lottery win 26.  
 (Insert Figure 2 about here) 
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These findings were largely consistent with our hypotheses, except for two 
unexpected observations. First, whilst an increase in sleep duration was associated 
with better MCS score, it was not associated with better PCS score at 4-year. This 
suggests that benefits of longer sleep do not necessarily emerge at the same speed 
or magnitude across different health domains. Benefits of longer sleep on physical 
health may take longer to emerge and may only be apparent in subgroups of short 
sleepers clocking <6 hours of sleep per night (n=2,867; 12% of the current sample at 
baseline). Second, changes in sleep quality were associated with subsequent health 
and wellbeing. This contrasts with the comparisons derived from a previous Finnish 
study, in which no effect on mortality was found for changes in sleep quality but 
consistent effects were observed for both changes in sleep quantity and an increase 
in sleep medication use 22. Arguably, mortality is a much broader and more distant 
measure of health and wellbeing. Differences in findings may also be explained by 
differences in sample constitution (Finnish vs. British) and length of follow-up (22 vs. 
4 years). That said, the current finding challenges the predominant focus on sleep 
quantity in some of the public health messages 28. Sleep may be better understood 
as a multidimensional experience, whereby quality of sleep is just as important as 
quantity. 
 
The current study benefited from the methodological strengths of UKHLS, which 
included its large sample size, representativeness of the sample, repeated 
assessments of the same individuals over multiple points, derived weights to account 
for sample attrition, and the use of well-validated health outcome measures 24. 
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However, the assessment of sleep was relatively coarse and each of the sleep 
parameter was measured with individual items derived from the PSQI. Objective 
measurement of sleep was not available; self-report data on sleep were arguably 
vulnerable to recall and reporting biases. We did not have information about the 
dose, frequency, duration of the sleep medication used. We also did not have 
information about the presence of any clinical sleep disorders (e.g., sleep apnoea), 
and thus were unable to control for these potential confounds in our analysis. 
However, we understand that the UKHLS did collect self-reported information on 
chronic medical conditions that may be linked to sleep (e.g., diabetes, asthma, 
cancer, epilepsy, depression, coronary heart disease etc.). It is possible for future 
research to run subgroup analysis to fine-tune our understanding of the sleep and 
health and wellbeing link as moderated by pre-existing medical conditions.  
 
We specifically examined the effect of changes in sleep and its impact on overall 
health and wellbeing over time, as this approach allowed us to establish temporal 
precedence between sleep improvement/disruptions and subsequent outcomes. 
Although conclusions concerning the causality between sleep improvement and 
better health cannot be drawn, integration of extant evidence from observational, 
experimental, and clinical studies suggests that the pathway from sleep changes to 
health can be both direct and indirect, through their effects on the circadian, 
homeostatic, metabolic, immune, pain, endocrine, cardiovascular, emotions, and 
memory systems and on the brain structures involved in the regulation of these 
overlapping systems 13, 19, 39-46. Analyses reported in this study were not designed to 
uncover the possible triggers of changes in sleep. There are many possible triggers, 
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including that natural process of aging and intentional and unintentional changes in 
health, diet, medication/substance use, lifestyle, exercise patterns, work conditions 
and life circumstances (e.g., divorce and unemployment). It would be a challenge for 
future research to provide a comprehensive list of these triggers and elucidate the 
neurophysiological mechanisms through which changes in these factors translate 
into sleep disruption or improvement. That said, the public health benefits of 
identifying what constitutes an effective avenue for protecting and improving sleep at 
the population level would be considerable. An excellent example is found in the 
body of work examining the association between sleep deprivation and medical 
errors, which has generated credible evidence suggesting that sleep deprivation as a 
result of long shift hours can increase daytime fatigue, clinical performance deficit, 
and medical errors among hospital residents 47-50. Recent intervention studies have 
shown that these undesirable consequences can be prevented or significantly 
reduced with innovations in shift scheduling that aims to eliminate extended shift and 
reduce work hours 51 and work policies that aim to safeguard a protected sleep 
period (of 5 hrs) during extended (up to 30 hrs) overnight in-hospital duty hours 52.  
 
In raising the public’s awareness of sleep and health, although the emphasis on 
protecting a critical amount of sleep is important, the focus of the message should be 
broadened to include the importance of getting sleep of good quality and of reducing 
dependence on sleep medication. On the latter point, the current study found that at 
baseline 16% of the sample reported use of sleep medication in the past month, with 
8.8% taking sleep medication three or more times a week. This level of prevalence is 
higher than that reported in France (10%; 6.17% on a chronic and frequent basis) 53 
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and the estimated level of prescribed hypnotic use in the US (4%) 54. Of relevance, 
those who increased their use of sleep medication over time reported worse 
outcomes despite the intended purpose of the medication to improve sleep and 
overall health and wellbeing. These findings align with work by Kripke and colleagues 
55 and Sivertsen and colleagues 56, revealing a dose-response relationship of 
hypnotic prescriptions with hazards of cancer and even death.  
 
Overall, the current study has provided fresh evidence in support of a temporal effect 
of sleep changes on health and wellbeing. This relationship applies to both negative 
and positive changes in sleep duration, sleep quality and use of sleep medication.  
Sleep is therefore a logical and feasible target for preventative health intervention.  
 
 
 
 
	   20	  
References  1.	   Ferrie	  JE,	  Kumari	  M,	  Salo	  P,	  Singh-­‐Manoux	  A,	  Kivimaki	  M.	  Sleep	  epidemiology-­‐-­‐a	  rapidly	  growing	  field.	  Int	  J	  Epidemiol	  2011;40:1431-­‐7.	  2.	   Institute	  of	  Medicine.	  Sleep	  disorder	  and	  sleep	  deprivation:	  an	  unmet	  public	  health	  problem.	  In.	  Washington,	  DC:	  The	  National	  Academies	  Press,	  2006.	  3.	   Mental	  Health	  Foundation.	  Sleep	  Matters.	  The	  impace	  of	  sleep	  on	  health	  and	  wellbeing.	  In.	  London,	  UK:	  Mental	  Health	  Foundation,	  2011.	  4.	   World	  Health	  Organization.	  WHO	  technical	  meeting	  on	  sleep	  and	  health.	  Bonn,	  Germany:	  World	  Health	  Organization,	  2004.	  5.	   Cappuccio	  FP,	  Miller	  MA,	  Lockley	  SW.	  Sleep,	  Health	  and	  Society:	  From	  Aetiology	  to	  Public	  Health.	  Oxford:	  Oxford	  University	  Press,	  2010.	  6.	   Åkerstedt	  T,	  Fredlund	  P,	  Gillberg	  M,	  Jansson	  B.	  Work	  load	  and	  work	  hours	  in	  relation	  to	  disturbed	  sleep	  and	  fatigue	  in	  a	  large	  representative	  sample.	  J	  Psychosom	  Res	  2002;53:585-­‐8.	  7.	   Léger	  D,	  Massuel	  M-­‐A,	  Metlaine	  A,	  TheSISYPHEStudyGroup.	  Professional	  Correlates	  of	  Insomnia.	  Sleep	  2006;29:171-­‐8.	  8.	   Shahly	  V,	  Berglund	  PA,	  Coulouvrat	  C,	  et	  al.	  The	  associations	  of	  insomnia	  With	  costly	  workplace	  accidents	  and	  errors.	  Results	  from	  the	  America	  insomnia	  survey.	  Arch	  Gen	  Psychiatry	  2012;69:1054-­‐63.	  9.	   Riemann	  D,	  Voderholzer	  U.	  Primary	  insomnia:	  a	  risk	  factor	  to	  develop	  depression?	  J	  Afffect	  Disorders	  2003;76:255-­‐9.	  10.	   Patel	  SR,	  Hu	  FB.	  Short	  sleep	  duration	  and	  weight	  gain:	  a	  systematic	  review.	  Obesity	  2008;16:643-­‐53.	  11.	   Cappuccio	  FP,	  D'Elia	  L,	  Strazzullo	  P,	  Miller	  MA.	  Quantity	  and	  quality	  of	  sleep	  and	  incidence	  of	  type	  2	  diabetes:	  a	  systematic	  review	  and	  meta-­‐analysis.	  Diabetes	  Care	  2010;33:414-­‐20.	  12.	   Wang	  Q,	  Xi	  B,	  Liu	  M,	  Zhang	  Y,	  Fu	  M.	  Short	  sleep	  duration	  is	  associated	  with	  hypertension	  risk	  among	  adults:	  a	  systematic	  review	  and	  meta-­‐analysis.	  Hypertens	  Res	  2012;35:1012-­‐8.	  13.	   Cappuccio	  FP,	  Cooper	  D,	  D'Elia	  L,	  Strazzullo	  P,	  Miller	  MA.	  Sleep	  duration	  predicts	  cardiovascular	  outcomes:	  a	  systematic	  review	  and	  meta-­‐analysis	  of	  prospective	  studies.	  Eur	  Heart	  J	  2011;32:1484-­‐92.	  14.	   Cappuccio	  FP,	  D'Elia	  L,	  Strazzullo	  P,	  Miller	  MA.	  Sleep	  duration	  and	  all-­‐cause	  mortality:	  a	  systematic	  review	  and	  meta-­‐analysis	  of	  prospective	  studies.	  Sleep	  2010;33:585-­‐92.	  15.	   Gallicchio	  L,	  Kalesan	  B.	  Sleep	  duration	  and	  mortality:	  a	  systematic	  review	  and	  meta-­‐analysis.	  J	  Sleep	  Res	  2009;18:148-­‐58.	  16.	   Kripke	  DF,	  Langer	  RD,	  Elliott	  JA,	  Klauber	  MR,	  Rex	  KM.	  Mortality	  related	  to	  actigraphic	  long	  and	  short	  sleep.	  Sleep	  Med	  2011;12:28-­‐33.	  17.	   Ferrie	  JE,	  Shipley	  MJ,	  Akbaraly	  TN,	  Mamot	  MG,	  Kivimäki	  M,	  Singh-­‐Manoux	  A.	  Change	  in	  sleep	  duration	  and	  cognitive	  function:	  findings	  from	  the	  Whitehall	  II	  study.	  Sleep	  2011;34:565-­‐73.	  18.	   Ferrie	  JE,	  Kivimäki	  M,	  Akbaraly	  TN,	  et	  al.	  Associations	  between	  change	  in	  sleep	  duration	  and	  inflammation:	  findings	  on	  C-­‐reactive	  protein	  and	  interleukin	  6	  in	  the	  Whitehall	  II	  Study.	  .	  American	  Journal	  of	  Epidemiology	  2013;178:956-­‐61.	  19.	   Irwin	  MR.	  Why	  sleep	  is	  important	  for	  health:	  a	  psychoneuroimmunology	  perspective.	  Annu	  Rev	  Psychol	  2015;66:143-­‐72.	  
	   21	  
20.	   Chaput	  JP,	  Bouchard	  C,	  Tremblay	  A.	  Change	  in	  sleep	  duration	  and	  visceral	  fat	  accumulation	  over	  6	  years	  in	  adults.	  Obesity	  2014;22:E9-­‐12.	  21.	   Chaput	  JP,	  Despres	  JP,	  Bouchard	  C,	  Tremblay	  A.	  Longer	  sleep	  duration	  associates	  with	  lower	  adiposity	  gain	  in	  adult	  short	  sleepers.	  Int	  J	  Obes	  2012;36:752-­‐6.	  22.	   Hublin	  C,	  Partinen	  M,	  Koskenvuo	  M,	  Kaprio	  J.	  Sleep	  and	  mortality:	  a	  population-­‐based	  22-­‐year	  follow-­‐up	  study.	  Sleep	  2007;30:1245-­‐53.	  23.	   University	  of	  Essex.	  Institute	  for	  Social	  and	  Economic	  Research	  and	  NatCen	  Social	  Research,	  Understanding	  Society:	  Waves	  1-­‐5,	  2009-­‐2014	  [computer	  file].	  In.	  7th	  ed.	  Colchester,	  Essex:	  UK	  Data	  Archive,	  November	  2015.	  24.	   Buck	  N,	  McFall	  S.	  Understanding	  Society:	  design	  overview.	  Longit	  Life	  Course	  Stud	  2012;3:5-­‐17.	  25.	   Boreham	  R,	  Boldysevaite	  D,	  Killpack	  C.	  UKHLS:	  Wave	  1	  Technical	  Report.	  UK:	  National	  Centre	  for	  Social	  Research,	  2012.	  26.	   Jessop	  C,	  Oskala	  A.	  UKHLS	  Wave	  4	  Technical	  Report.	  .	  UK:	  National	  Centre	  for	  Social	  Research,	  2014.	  27.	   Buysse	  DJ,	  Reynolds	  CF,	  Monk	  TH,	  Berman	  SR,	  Kupfer	  DJ.	  The	  Pittsburgh	  Sleep	  Quality	  Index:	  a	  new	  instrument	  for	  psychiatric	  practice	  and	  research.	  .	  Psychiatry	  Research	  1989;28:193-­‐213.	  28.	   Carpenter	  JS,	  Andrykowski	  MA.	  Psychometric	  evaluation	  of	  the	  Pittsburgh	  sleep	  quality	  index.	  Journal	  of	  Psychosomatic	  Research	  1998;45:5-­‐13.	  29.	   Gentili	  A,	  Weiner	  D,	  Kuchibhatla	  M,	  Edinger	  J.	  Test–retest	  reliability	  of	  the	  Pittsburgh	  Sleep	  Quality	  Index	  in	  nursing	  home	  residents	  [letter].	  Journal	  of	  the	  American	  Geriatrics	  Society	  1995;43:1317-­‐8.	  30.	   Goldberg	  DP,	  Gater	  R,	  Sartorius	  N,	  et	  al.	  The	  validity	  of	  two	  versions	  of	  the	  GHQ	  in	  the	  WHO	  study	  of	  mental	  illness	  in	  general	  health	  care.	  Psychol	  Med	  1997;27:191-­‐7.	  31.	   Goldberg	  D.	  General	  Health	  Questionnaire	  (GHQ-­‐12).	  Windsor,	  UK:	  NFER-­‐Nelson,	  1992.	  32.	   Ware	  JE,	  Kosinski	  M,	  Keller	  SD.	  A	  12-­‐Item	  Short-­‐Form	  Health	  Survey:	  construction	  of	  scales	  and	  preliminary	  tests	  of	  reliability	  and	  validity.	  Med	  Care	  1996;34:220-­‐33.	  33.	   Little	  RJA.	  Regression	  with	  missing	  X's:	  a	  review.	  J	  Am	  Stat	  Assoc	  1992;87.	  34.	   Little	  RJA,	  Rubin	  DB.	  Statistical	  analysis	  with	  missing	  data.	  Hoboken,	  NJ:	  John	  Wiley	  &	  Sons	  Inc,	  2014.	  35.	   Van	  Buuren	  S.	  Flexible	  imputation	  of	  missing	  data.	  Boca	  Raton,	  FL:	  CRC	  Press,	  2012.	  36.	   Van	  Buuren	  S,	  Brand	  JPL,	  Groothuis-­‐Oudshoorn	  CGM,	  Rubin	  DB.	  Fully	  conditional	  specification	  in	  multivariate	  imputation.	  J	  Stat	  Comput	  Sim	  2006;76:1049-­‐64.	  37.	   Van	  Buuren	  S,	  Groothuis-­‐Oudshoorn	  K.	  mice:	  multivariate	  imputation	  by	  chained	  equations	  in	  R.	  J	  Stat	  Softw	  2011;45.	  38.	   Knies	  G.	  Understanding	  Society	  –	  UK	  Household	  Longitudinal	  Study:	  Wave	  1-­‐4,	  2009-­‐2013,	  User	  Manual.	  In.	  Colchester,	  Essex:	  University	  of	  Essex,	  2014.	  39.	   Baglioni	  C,	  Spiegelhalder	  K,	  Lombardo	  C,	  Riemann	  D.	  Sleep	  and	  emotions:	  a	  focus	  on	  insomnia.	  Sleep	  Med	  Rev	  2010;14:227-­‐38.	  40.	   Lautenbacher	  S,	  Kundermann	  B,	  Krieg	  JC.	  Sleep	  deprivation	  and	  pain	  perception.	  Sleep	  Med	  Rev	  2006;10:357-­‐69.	  41.	   Riemann	  D,	  Kloepfer	  C,	  Berger	  M.	  Functional	  and	  structural	  brain	  alterations	  in	  insomnia:	  implications	  for	  pathophysiology.	  Eur	  J	  Neurosci	  2009;29:1754-­‐60.	  
	   22	  
42.	   Saper	  CB,	  Scammell	  TE,	  Lu	  J.	  Hypothalamic	  regulation	  of	  sleep	  and	  circadian	  rhythms.	  Nature	  2005;437:1257-­‐63.	  43.	   Van	  Cauter	  E,	  Holmback	  U,	  Knutson	  K,	  et	  al.	  Impact	  of	  sleep	  and	  sleep	  loss	  on	  neuroendocrine	  and	  metabolic	  function.	  Horm	  Res	  2007;67	  Suppl	  1:2-­‐9.	  44.	   Walker	  MP,	  Stickgold	  R.	  Sleep,	  memory,	  and	  plasticity.	  Annu	  Rev	  Psychol	  2006;57:139-­‐66.	  45.	   Riemann	  D,	  Spiegelhalder	  K,	  Feige	  B,	  et	  al.	  The	  hyperarousal	  model	  of	  insomnia:	  a	  review	  of	  the	  concept	  and	  its	  evidence.	  Sleep	  Med	  Rev	  2010;14:19-­‐31.	  46.	   Dijk	  DJ,	  Duffy	  JF,	  Czeisler	  CA.	  Age-­‐related	  increase	  in	  awakenings:	  impaired	  consolidation	  of	  nonREM	  sleep	  at	  all	  circadian	  phases.	  Sleep	  Medicine	  Reviews	  2001;24:565-­‐77.	  47.	   Arnedt	  JT,	  Owens	  J,	  Crouch	  M,	  Stahl	  J,	  Carskadon	  MA.	  Neurobehavioral	  Performance	  of	  Residents	  After	  Heavy	  Night	  Call	  vs	  After	  Alcohol	  Ingestion.	  Obstetrical	  &	  Gynecological	  Survey	  2006;61:17-­‐9.	  48.	   Barger	  LK,	  Ayas	  NT,	  Cade	  BE,	  et	  al.	  Impact	  of	  Extended-­‐Duration	  Shifts	  on	  Medical	  Errors,	  Adverse	  Events,	  and	  Attentional	  Failures.	  PLoS	  Med	  2006;3:e487.	  49.	   Eastridge	  BJ,	  Hamilton	  EC,	  O’Keefe	  GE,	  et	  al.	  Effect	  of	  sleep	  deprivation	  on	  the	  performance	  of	  simulated	  laparoscopic	  surgical	  skill.	  The	  American	  Journal	  of	  Surgery;186:169-­‐74.	  50.	   Philibert	  I.	  Sleep	  loss	  and	  performance	  in	  residents	  and	  nonphysicians:	  a	  meta-­‐analytic	  examination	  .	  Sleep	  2005;28:1392-­‐402.	  51.	   Landrigan	  	  CP,	  Rothschild	  	  JM,	  Cronin	  	  JW,	  et	  al.	  Effect	  of	  Reducing	  Interns'	  Work	  Hours	  on	  Serious	  Medical	  Errors	  in	  Intensive	  Care	  Units.	  New	  England	  Journal	  of	  Medicine	  2004;351:1838-­‐48.	  52.	   Volpp	  KG,	  Shea	  JA,	  Small	  DS,	  et	  al.	  Effect	  of	  a	  protected	  sleep	  period	  on	  hours	  slept	  during	  extended	  overnight	  in-­‐hospital	  duty	  hours	  among	  medical	  interns:	  a	  randomized	  trial.	  .	  Journal	  of	  American	  Medical	  Association	  2012;308:2208-­‐17.	  53.	   Quera-­‐Salva	  MA,	  Orluc	  A,	  Goldenberg	  F,	  Guilleminault	  C.	  Insomnia	  and	  use	  of	  hynotics:	  study	  of	  a	  French	  population.	  Sleep	  1991;14:386-­‐91.	  54.	   Chong	  Y,	  Fryar	  CD,	  Gu	  Q.	  Prescription	  sleep	  aid	  use	  among	  adults:	  United	  States,	  2005–2010.	  NCHS	  data	  brief,	  no	  127.	  Hyattsville,	  MD:	  Centers	  for	  Disease	  Control	  and	  Prevention	  2013.	  55.	   Kripke	  DF,	  Langer	  RD,	  Kline	  LE.	  Hypnotics'	  association	  with	  mortality	  or	  cancer:	  a	  matched	  cohort	  study.	  BMJ	  Open	  2012;2:e000850.	  56.	   Sivertsen	  B,	  Harvey	  AG,	  Pallesen	  S,	  Hysing	  M.	  Mental	  health	  problems	  in	  adolescents	  with	  delayed	  sleep	  phase:	  results	  from	  a	  large	  population‐based	  study	  in	  Norway.	  .	  Journal	  of	  Sleep	  Research	  2015;24:11-­‐8.	  	  	  	  
